![]() |
|
|
Vol. 281, Issue 3, 1013-1029, 1997
Department of Psychology, Rutgers University, New Brunswick, New
Jersey
To investigate the interaction between alprazolam and caffeine,
performance on a differential reinforcement of low-rate behavior schedule and the respective pharmacokinetics (PK) were explored in
concurrent studies. Alprazolam PK was not altered by caffeine, but
alprazolam retarded caffeine absorption indirectly, as inferred by the
lack of i.v. drug administration PK interaction, thereby decreasing
serum methylxanthine concentrations. Inasmuch as alprazolam was more
potent and short-lived than caffeine in decreasing the reinforcement
rate (consonant with their respective t1/2
values, 0.44 and 3.1 hr), the alprazolam/caffeine potency ratio
decreased across the session time, which determined the expression of
the combined effects. Thus, the decreased methylxanthine level yielded slightly less disruption in performance for the observed combined effect, compared to the expected calculated effect, only near the end
of a session. The interaction was PK linked and mainly not
distinguishable from independence as indicated by the Pöch dose-response curve method and the integration of PK and
pharmacodynamics. The sigmoid maximal effect-link pharmacodynamic model
indicated that caffeine did not alter the concentration at half of the
maximal effect value of alprazolam and suggested that the interaction is not competitive, but independent. Although the nature of the benzodiazepine-methylxanthine interaction has been controversial in
other behavioral studies, as is the role of PK in determining behavior,
this and our previous study make it evident that the interaction is
independent not only across doses and routes of administration, but
also with respect to two indices of differential reinforcement of low
rate performance.